Thermo Fisher Scientific Inc (NYSE:TMO) under-valued by 8%
| Website | https://www.thermofisher.com/ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Fiscal Year End | Dec 31, 2020 |
| Market Cap | $184,108,810,240 |
| Beta | 0.768891 |
| Average Volume | $1,750,176 |
| Last Dividend | 0.92% |
| Price on May 7, 2021 | $468.45 |
| Autochartist™ Valuation | $507.59 |
| Conclusion |
8% under-valued |
| Download Report |
